Standard Biotools | FLDM - Cash And Equivalent



Standard Biotools reported $158.62M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Agilent USD 1.54B 49M Jul/2025
Becton, Dickinson and Co. USD 735M 68M Jun/2025
Bio-Rad Laboratories USD 369.3M 152.1M Jun/2025
Bruker USD 92M 92.2M Jun/2025
Danaher USD 2.96B 964M Jun/2025
Illumina USD 934M 179M Jun/2025
Myriad Genetics USD 91.8M 10.6M Mar/2025
Nikon Corporation JPY 164.74B 1.15B Jun/2025
Revvity USD 991.85M 145.77M Jun/2025
Roche Holding CHF 6.98B 2.15B Dec/2024
Sony JPY 1.6T 1.38T Jun/2025
Standard Biotools USD 158.62M 8.11M Jun/2025
Thermo Fisher Scientific USD 4.58B 442M Jun/2025
Waters USD 367.22M 15.66M Jun/2025